WAY-213613
CAS No. 868359-05-1
WAY-213613 ( —— )
Catalog No. M24877 CAS No. 868359-05-1
WAY-213613 is a potent and selective nonsubstrate reuptake inhibitor of GLT-1/EAAT2 (IC50: 85 nM EAAT2).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 189 | In Stock |
|
10MG | 285 | In Stock |
|
25MG | 505 | In Stock |
|
50MG | 759 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWAY-213613
-
NoteResearch use only, not for human use.
-
Brief DescriptionWAY-213613 is a potent and selective nonsubstrate reuptake inhibitor of GLT-1/EAAT2 (IC50: 85 nM EAAT2).
-
DescriptionWAY-213613 is a potent and selective nonsubstrate reuptake inhibitor of GLT-1/EAAT2 (IC50: 85 nM EAAT2). It displays 59- and 44-fold selectivity over EAAT1 and EAAT3 (IC50s: 5 and 3.8 μM, respectively). WAY-213613 shows no activity at ionotropic and metabotropic glutamate receptors.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorEAAT2;EAAT3;EAAT1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number868359-05-1
-
Formula Weight415.2
-
Molecular FormulaC16H13BrF2N2O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN[C@@H](CC(Nc(cc1)ccc1Oc(cc(c(F)c1)F)c1Br)=O)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dunlop J, et al. Characterization of novel aryl-ether, biaryl, and fluorene aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT2. Mol Pharmacol. 2005 Oct;68(4):974-82. Epub 2005 Jul 13.
molnova catalog
related products
-
Protoescigenin
Protoescigenin is a natural product.
-
Fortunellin
Fortunellin is a natural product for research related to life sciences.
-
Moschamine
Moschamine is a very potent compound that is able to inhibit COX-I by 58% and COX-II by 54%, at the concentration of 0.1 μmol L⁻1, it may suppress cAMP formation via binding to 5-HT1 receptors in the cells. Moschamine exerts antitumour effects on HeLa, MCF7 and A431 cells.